EcoDrugPlus

Ensembl ID : ENSOMYG00000022161
Gene Symbol: -
Cross references: -
221 Possible Orthologues:

Ensembl ID : ENSOMYG00000044107
Gene Symbol: -
1 Cross references
20 Possible Orthologues:

Ensembl ID : ENSOMYG00000045036
Gene Symbol: -
Cross references: -
188 Possible Orthologues:

Ensembl ID : ENSOMYG00000045059
Gene Symbol: VDRB
1 Cross references
385 Possible Orthologues:

Ensembl ID : ENSOMYG00000045162
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSOMYG00000045211
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSOMYG00000045376
Gene Symbol: -
Cross references: -
132 Possible Orthologues:

Ensembl ID : ENSOMYG00000045596
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSOMYG00000045675
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSOMYG00000045714
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSOMYG00000045241
Gene Symbol: -
Cross references: -
173 Possible Orthologues:

Ensembl ID : ENSOMYG00000021936
Gene Symbol: -
Cross references: -
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).